Search Results 61-70 of 13566 for Thyroid eye disease
Participation eligibility · Subjects must be ≥ 18 years of age at Screening. · Clinical diagnosis of Graves' Disease and/or autoimmune Hashimoto's thyroiditis ...
In Graves' disease (GD), despite a contemporary shift toward thyroid preservation using antithyroid drugs, these medications often fail to induce durable ...
... thyroid eye disease or Graves' ophthalmopathy — for many years. That tradition of innovation in research of thyroid disorders continues today. Mayo Clinic ...
This is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED).
Mayo Clinic has been researching and treating Graves' disease and its associated eye-related changes — called thyroid eye disease or Graves' ophthalmopathy — ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.